advertisement

Accelerate your drug discovery pipeline with AI-powered molecular modelling

BioSim Pro · Trusted by 400+ research institutions globally · 30-day free trial

CRISPR base editing corrects sickle cell mutation in 97% of patient cells · Phase III mRNA cancer vaccine shows 44% reduction in recurrence · Gut microbiome linked to treatment-resistant depression — Nature study · Novo Nordisk acquires rare disease biotech for $3.2B · FDA grants breakthrough designation to novel Alzheimer's antibody ·
CRISPR base editing corrects sickle cell mutation in 97% of patient cells · Phase III mRNA cancer vaccine shows 44% reduction in recurrence · Gut microbiome linked to treatment-resistant depression — Nature study · Novo Nordisk acquires rare disease biotech for $3.2B · FDA grants breakthrough designation to novel Alzheimer's antibody ·

Legal & Privacy Centre · Updated April 2026

Transparency & Your Rights

Biomed Today is committed to being clear, honest and fair about how we operate. This page covers our Privacy Policy, Terms of Use, Accessibility Statement, and Cookie Settings — everything you need to understand your rights and how we handle your information.

Terms of Use

Effective: April 2026 · Last reviewed: April 2026

Summary: By using Biomed Today you agree to these terms. You must be 18 or over. Our editorial content is our intellectual property — you can share links and cite us but not republish. Third-party and sponsored content is published as submitted and clearly labelled. Nothing here is medical advice.

1. Acceptance of Terms

By accessing or using the Biomed Today website at biomedtoday.com or subscribing to our newsletter, you agree to be bound by these Terms of Use. If you do not agree, please do not use our services. These terms apply to all content on our platform — articles, newsletters, research summaries, expert opinions, sponsored content, images, and any other material published by or through Biomed Today.

2. Who May Use Our Services

3. Intellectual Property

4. Third-Party and Sponsored Content

5. Graphical Abstracts and Scientific Materials

Scientific images, graphical abstracts, and research illustrations submitted for publication are used solely to describe and communicate the associated research. They are not used in advertising, redistributed to third parties, or reproduced in any commercial context beyond publication on our platform. Intellectual property rights remain with the submitting researcher or institution at all times. Materials may be removed upon written request to biomedtodaynews@gmail.com.

6. Medical and Scientific Disclaimer

Content published on Biomed Today is for informational and educational purposes only. Nothing on our platform constitutes medical advice, clinical guidance, or a recommendation for any treatment, therapy, or product. Always consult a qualified healthcare professional before making any medical decision.

7. Acceptable Use

8. Content Submissions

9. Limitation of Liability

10. Governing Law

11. Changes to These Terms

Data & Privacy Enquiries

For any question about your data, your rights, or this policy, contact us directly. We respond within 30 working days.

Policy Dates